BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37004423)

  • 21. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
    Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
    BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
    Batta N; Pandey M
    World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma.
    Ding YF; Lin YW; Chiu WK; Lin CW; Yang YC; Chang LC; Chang J; Yang SF; Chien MH
    Aging (Albany NY); 2022 May; 14(10):4500-4512. PubMed ID: 35587368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes.
    Xie F; Gleue CA; Deschaine M; Dasari S; Lau JS; Sartori-Valinotti JC; Meves A; Lehman JS
    J Oral Pathol Med; 2022 Apr; 51(4):395-404. PubMed ID: 35146808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
    Li B; Chen X; Xian H; Wen Q; Wang T
    PeerJ; 2023; 11():e16392. PubMed ID: 38050610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
    Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
    Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Yang X; Song H; Ji T; Du G; Liu W
    Oral Oncol; 2022 Jul; 130():105924. PubMed ID: 35594773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
    Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
    ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
    Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers.
    Arunkumar G; Murugan AK; Nagarajan M; Ajay C; Rajaraman R; Munirajan AK
    Oral Dis; 2017 Jul; 23(5):669-673. PubMed ID: 28181739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma.
    Kuk SK; Lee JI; Kim K
    Head Neck Pathol; 2023 Jun; 17(2):409-421. PubMed ID: 36586077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
    Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
    Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive genomic characterization of head and neck squamous cell carcinomas.
    Cancer Genome Atlas Network
    Nature; 2015 Jan; 517(7536):576-82. PubMed ID: 25631445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.